Shares of Clover Health Investments, Corp. CLOV rose sharply during Wednesday’s session after the company reported better-than-expected fourth-quarter revenue results and issued FY24 insurance revenue guidance.
Clover Health Investments reported quarterly sales of $510.3 million which beat the analyst consensus estimate of $480.25 million by 6.26% and represents a 43.22% decrease over sales of $898.79 million the same period last year.
Clover Health Investments shares climbed 11.2% to $0.8537 on Wednesday.
Here are some other stocks moving in today's mid-day session.
Gainers
- Gaxos.ai Inc. GXAI shares jumped 128.9% to $12.18 after the company announced it acquired the rights to use certain AI-enabled technology from Ultiself.
- Veritone, Inc. VERI gained 52.4% to $2.6076 following strong sales results.
- NuCana plc NCNA gained 50.2% to $0.5869 after the company was granted a US Patent for "Phosphoramidate Derivatives For Use In The Treatment Of Cancer; Especially In The Treatment Where The Patient Shows Resistance."
- The Beauty Health Company SKIN rose 31.9% to $4.7350 after the company reported better-than-expected fourth-quarter revenue results.
- Arq, Inc. ARQ gained 28.3% to $4.4522 after the company reported upbeat fourth-quarter results.
- MicroCloud Hologram Inc. HOLO jumped 26.6% to $6.19.
- Kintara Therapeutics, Inc. KTRA shares gained 26.2% to $0.1055.
- Nature's Sunshine Products, Inc. NATR jumped 24.7% to $21.47 after the company reported better-than-expected fourth-quarter adjusted EPS results and issued FY24 net sales guidance.
- Heron Therapeutics, Inc. HRTX gained 24.7% to $2.9428 after the company reported better-than-expected fourth-quarter adjusted EPS results and issued FY24 revenue guidance. Also, Needham maintained a Buy rating on the stock and raised its price target from $4 to $5.
- Li-Cycle Holdings Corp. LICY shares gained 23.2% to $0.7233. Li-Cycle shares jumped 46% on Tuesday after the company entered an agreement to issue a senior secured convertible note in an aggregate principal amount of $75 million to an affiliate of Glencore.
- Cue Biopharma, Inc. CUE gained 19.2% to $2.11 after Jefferies initiated coverage on the stock with a Buy rating and $6 price target.
- AdTheorent Holding Company, Inc. ADTH surged 19% to $3.4150 following strong sales.
- SIGA Technologies, Inc. SIGA gained 18.8% to $6.32 after the company reported a year-over-year increase in quarterly financial results.
- Educational Development Corporation EDUC surged 18.1% to $2.0432.
- Portage Biotech Inc. PRTG gained 17.7% to $0.6589.
- Williams-Sonoma, Inc. WSM climbed 17.7% to $283.70 after the company reported better-than-expected fourth-quarter earnings, announced a new $ 1 billion stock repurchase authorization and increased its quarterly dividend.
- HUTCHMED (China) Limited HCM shares climbed 15.8% to $18.91 after gaining 9% on Tuesday.
- Annexon, Inc. ANNX rose 15% to $5.28. Needham analyst Joseph Stringer reiterated Annexon with a Buy and maintained a $16 price target.
- Mind Medicine (MindMed) Inc. MNMD gained 13.2% to $8.90.
- Full Truck Alliance Co. Ltd. YMM climbed 11.2% to $7.74. Full Truck Alliance announced extension of share repurchase program up to $300 million.
- Summit Therapeutics Inc. SMMT gained 10% to $4.7450.
- Qilian International Holding Group Limited QLI climbed 10% to $0.6052.
- PBF Energy Inc. PBF gained 9.4% to $55.18.
- BeiGene, Ltd. BGNE shares climbed 9% to $178.44.
- Minim, Inc. MINM gained 8.3% to $5.43 after the company announced that it entered into a definitive merger agreement with e2Companies.
- Recursion Pharmaceuticals, Inc. RXRX rose 7% to $ 11.27.
Losers
- voxeljet AG VJET shares fell 40.8% to $0.5922 after the company announced it will voluntarily delist its ADSs from Nasdaq and deregister its ADSs. The company also announced the restatement and extension of its loan financing with Anzu.
- Luna Innovations Incorporated LUNA fell 39% to $3.82 after the company announced that it will delay the release of its fourth-quarter and FY23 financial results. and said financial statements for the quarters ended Jun. 30 and Sept. 30 should no longer be relied upon.
- SurgePays, Inc. SURG fell 30.5% to $4.86 after the company reported worse-than-expected fourth-quarter financial results.
- P3 Health Partners Inc. PIII fell 29.4% to $0.72.
- SOS Limited SOS dipped 28% to $1.5399 G
- Allbirds, Inc. BIRD declined 25.3% to $0.6952 after the company reported worse-than-expected fourth-quarter GAAP EPS results.
- Fangdd Network Group Ltd. DUO fell 23.3% to $0.5710.
- WideOpenWest, Inc. WOW fell 21.1% to $2.7290 after the company reported worse-than-expected fourth-quarter financial results and issued guidance.
- NaaS Technology Inc. NAAS fell 20.1% to $1.19 after the company announced a $6 million registered direct offering.
- Comtech Telecommunications Corp. CMTL fell 19% to $4.6599. Comtech named John Ratigan as Interim Chief Executive Officer.
- Aterian, Inc. ATER tumbled 19% to $0.3783 following quarterly results.
- Psyence Biomedical Ltd. PBM fell 17.8% to $1.01.
- reAlpha Tech Corp. AIRE fell 16.3% to $1.07 after the company reported EPS for the eight months ended Dec. 31, 2023.
- loanDepot, Inc. LDI fell 15.9% to $2.1350 following weak quarterly results.
- Bit Origin Ltd BTOG fell 15.7% to $4.45 after gaining 11% on Tuesday.
- Dollar Tree, Inc. DLTR declined 14.5% to $128.00 after the company reported worse-than-expected fourth-quarter financial results and issued first-quarter EPS guidance below estimates.
- Rackspace Technology, Inc. RXT dipped 13.3% to $1.9150 after the company issued first-quarter guidance below estimates. The company also announced refinancing transactions.
- ZIM Integrated Shipping Services Ltd. ZIM fell 12.4% to $10.22 following weak quarterly sales.
- Neumora Therapeutics, Inc. NMRA declined 12.2% to $15.24.
- ECD Automotive Design, Inc. ECDA dipped 10.8% to $1.07 after jumping over 13% on Tuesday.
- Solowin Holdings SWIN fell 8.6% to $26.61.
Now Read This: NVIDIA To Rally Around 20%? Here Are 10 Top Analyst Forecasts For Wednesday
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.